T

Tongling Jieya Biologic Technology Co Ltd
SZSE:301108

Watchlist Manager
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Watchlist
Price: 28.1 CNY -0.64% Market Closed
Market Cap: 2.3B CNY
Have any thoughts about
Tongling Jieya Biologic Technology Co Ltd?
Write Note

Tongling Jieya Biologic Technology Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tongling Jieya Biologic Technology Co Ltd
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
T
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Accounts Payable
ÂĄ123.6m
CAGR 3-Years
-2%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Accounts Payable
ÂĄ2.4B
CAGR 3-Years
10%
CAGR 5-Years
-2%
CAGR 10-Years
-2%
Proya Cosmetics Co Ltd
SSE:603605
Accounts Payable
ÂĄ1.1B
CAGR 3-Years
24%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Accounts Payable
ÂĄ334.4m
CAGR 3-Years
42%
CAGR 5-Years
39%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Accounts Payable
ÂĄ426.6m
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Accounts Payable
ÂĄ257.6m
CAGR 3-Years
94%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tongling Jieya Biologic Technology Co Ltd
Glance View

Market Cap
2.3B CNY
Industry
Consumer products

Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sale of wet wipes. The company is headquartered in Tongling, Anhui and currently employs 798 full-time employees. The company went IPO on 2021-12-03. The firm's main businesses are the research and development, production and sales of sanitary products. The firm's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The firm is also engaged in the production of facial masks.

Intrinsic Value
22.97 CNY
Overvaluation 18%
Intrinsic Value
Price
T

See Also

What is Tongling Jieya Biologic Technology Co Ltd's Accounts Payable?
Accounts Payable
123.6m CNY

Based on the financial report for Dec 31, 2023, Tongling Jieya Biologic Technology Co Ltd's Accounts Payable amounts to 123.6m CNY.

What is Tongling Jieya Biologic Technology Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
28%

Over the last year, the Accounts Payable growth was 36%. The average annual Accounts Payable growth rates for Tongling Jieya Biologic Technology Co Ltd have been -2% over the past three years , 28% over the past five years .

Back to Top